Aberdeen Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Buy |
521,492
+117,338
| +29% | +$3.67M | 0.03% | 471 |
|
|
2025
Q1 | $13.6M | Buy |
404,154
+120,255
| +42% | +$4.03M | 0.03% | 491 |
|
|
2024
Q4 | $11.1M | Buy |
283,899
+35,588
| +14% | +$1.4M | 0.02% | 491 |
|
|
2024
Q3 | $9.78M | Buy |
248,311
+35,809
| +17% | +$1.41M | 0.02% | 526 |
|
|
2024
Q2 | $8.29M | Buy |
212,502
+180,466
| +563% | +$7.04M | 0.02% | 542 |
|
|
2024
Q1 | $1.38M | Hold |
32,036
| – | – | ﹤0.01% | 805 |
|
|
2023
Q4 | $1.48M | Buy |
+32,036
| New | +$1.48M | ﹤0.01% | 800 |
|